Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Livea

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Livea head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 240 · Grade C

Livea

Visit Livea Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Livea a bad call — it's best for readers seeking nutrition and medical follow-up through a regional clinic network who can confirm location access and separate medication charges. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
84
Transparency
90
48
Access Breadth
93
56
Clinical Oversight
92
95
Track Record
88
80
CoreAge RxBrief Score 94 · 66Livea

Price, coverage & the tracker

CoreAge RxLivea
Brief Score94/100 (A)66/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Program and medication quote needed

Medical page: $69/month program access, with medication extra. Separate GLP-1 page: semaglutide from $99/month.

FAQ uses different medication-price wording; obtain the full selected bill and location eligibility.

Full price details

Semaglutide complete quote unknown; medical page says $69/month is program access with medication extra, while separate GLP-1 page advertises compounded semaglutide from $99/month

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Program and medication quote needed

Medical page: program access from $69/month, with medication extra. No complete tirzepatide quote established.

Compounded and branded options require clinical eligibility; confirm the full bill and physical-location access.

Full price details

Tirzepatide complete quote unknown; program access advertised from $69/month with medication extra; compounded and branded options require a selected eligibility and cost quote

CoverageUS only; restrictions by state, confirmed at intakeFAQ lists Minnesota, Wisconsin, Iowa and Florida; telehealth terms focus on Minnesota/Wisconsin or separately confirmed eligibility. Confirm physical-location access.
Brand-name accessNot confirmedFAQ specifically advertises branded Wegovy and Zepbound; selected availability, medication cost and insurance coverage require confirmation.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Livea: The medical page defines $69/month as program access and supervision, with medication extra. A separate page advertises semaglutide from $99; obtain the complete selected bill.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.